Intuitive Surgical (ISRG +3.1%) trades higher ahead of tomorrow's Q3 report and an upgrade to...
Monday, October 15, 2012, 2:39 PM ETIntuitive Surgical (ISRG +3.1%) trades higher ahead of tomorrow's Q3 report and an upgrade to Outperform by JPMorgan earlier today. The firm says that despite declines in domestic prostate-cancer surgeries there's compelling risk/reward in the shares, with meaningful opportunities emerging in other cancers and additional areas which, collectively, should more than offset the prostate-cancer softness and drive up Street estimates for the next several years.
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles